Flagship unveils latest brainchild: Ampersand Biomedicines By / On March 7, 2023 / At 4:13 pm / In Chemical world 6 Views The venture capital company commits $50 million to the start-up launch Post navigation Prev PostChemistry in Pictures: Big orange Next PostAAAS head wants ‘closer’ link between US and Horizon Europe You May Also Like Glow-in-the-dark proteins offer cheap and fast diagnostic tests On March 23, 2023 | In Chemical world Arsenite-induced necroptosis requires stress granules On March 22, 2023 | In Chemical world European response to US cleantech incentives leaves industry and environmentalists fuming On March 22, 2023 | In Chemical world